Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection

NCT04487444 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
56
Enrollment
OTHER
Sponsor class

Stopped The study was terminated due to slow enrollment and the transfer of the PI to another institution.

Conditions

Interventions

Sponsor

Rhode Island Hospital